Budget deficit up 23%

Plus, Ozempic for kids?

*past 24-hour performance

Upcoming Week:

  • Thursday: The Bureau of Economic Analysis (BEA) will issue the advance estimate for third-quarter U.S. gross domestic product (GDP)

  • Friday: The Bureau of Economic Analysis (BEA) will release the Personal Consumption Expenditures (PCE) Price Index for September, the Fed’s preferred inflation gauge

Notable Earnings:

  • Monday: Brown & Brown (BRO), WR Berkley (WRB), & Logitech (LOGI)

  • Tuesday: Microsoft (MSFT), Alphabet (GOOG), Visa (V), Coca Cola (KO), Novartis (NVS), Danaher (DHR), Texas Instruments (TXN), Verizon (VZ), GE (GE), RTX (RTX), NextEra Energy (NEE), Chubb (CB), 3M Company (MMM), General Motors (GM), & Spotify (SPOT)

  • Wednesday: Meta (META), IBM (IBM), & Boeing (BA)

  • Thursday: Amazon (AMZN), Mastercard (MA), Intel (INTC), Altria (MO), Chipotle (CMG), Ford (F), Keurig Dr Pepper (KDP), & Hershey (HSY)

  • Friday: Exxon Mobil (XOM), Chevron (CVX), & Abbvie (ABBV)

  • Solar stocks hit 3 year low: Solar stocks tumbled on Friday after solar product manufacturer Solaredge (SEDG) warned that demand in Europe has significantly weakened and the stock dropped ~28%. (CNBC)

  • Budget deficit up 23%: The U.S. government on Friday posted a $1.695 trillion budget deficit in fiscal 2023, a 23% jump from the prior year as revenues fell and outlays for Social Security, Medicare and record-high interest costs on the federal debt rose. (Reuters)

  • Insect protein: Tyson Foods (TSN), a prominent U.S. meat producer, has made an undisclosed investment in Dutch insect ingredient manufacturer Protix, which is building an "insect ingredient facility" in the U.S. (CNN)

  • Big shipping-container firm nears sale: Infrastructure investor Stonepeak is close to a deal to purchase shipping-container lessor Textainer (TGH) for more than $2 billion. (WSJ)

  • Ozempic for kids? Pharmaceutical companies are looking to get buzzy weight-loss shots approved for younger and younger patients. (Bloomberg)

  • Amex increases provisions: American Express (AXP) was the worst-performing stock in the Dow Friday as shares fell over 5% after the credit card provider boosted the money it put aside to cover for customers defaulting on their payments. (Investopedia)

No fixed income asset has outperformed US cash in 2023: Clearly, the NASDAQ (+28.1%) has trounced everything and has taken the S&P (+13.8%) with it. However, the equal weight S&P 500 has underperformed cash at just under 1% return YTD. In other words, aside for AI or Obesity-linked stocks, 2023 has been a dismal year. Read more »

Crisis Briefing: How to raise cash: Profiting from a crisis requires more than just the discipline to “be greedy when others are fearful,” as Warren Buffett famously said. You must also have the cash available to do so. Read more »

The AI bubble playbook: AI might be frothing, but objective comparison to a bonafide bubble says we’re nowhere near roaring insanity. The current AI bubble is closer to 1995 than 2000 using the Dotcom boom as a comparison. Read more »

  • Fish skin can heal other animals’ eye injuries (Scientific American)

  • The rise and fall of the bank robbery capital of the world (Crime Reads)

  • The Army is planning for a conflict with China—including shoring up blood supply (Defense One)

  • The great cash-for-carbon hustle (New Yorker)

  • For these 3 countries, the pendulum swings (Cody Shirk)

  • If the NFL feels different this year that’s because it is (Sharp)

Thunderclap Research is a professional investment research firm focused on understanding and profiting from market anomalies.

We take both a quantitative and qualitative approach to research and focus extensively on strategies for established money managers and everyday retail investors.

We are a small, self-funded team of real humans going up against the hype-filled, sensational news outlets in the world. You can check out a selection of our other publications below.

Gold PlaybookAll your gold investing news in a single daily email.
CoinSnacksDigestible crypto news.

Reply

or to participate.